All PlansAdministrativeMedium impact

Newsletter Vol. 11, No. 10

Q: Who is affected by this change?

This affects New Jersey Medicaid Family Medicine, Internal Medicine, Cardiology, General Practice providers in NJ on All Plans plans.

New Jersey Medicaid·NJ · Family Medicine, Internal Medicine, Cardiology +1 more·Pharmacy

Effective date

Not stated

We identified it

Jun 20, 2026

Days to comply

—

Summary

This policy addresses retrospective reviews of potential drug-drug interactions between warfarin and antibiotics. The policy appears to focus on pharmacy-related reviews that may impact billing for anticoagulation management and related services.

Action Required

Action needed

Review Newsletter Vol. 11, No. 10 from the full PDF document to understand specific requirements for warfarin/antibiotic interaction documentation and any billing implications for anticoagulation management services. Ensure providers document drug interaction assessments when prescribing antibiotics to patients on warfarin therapy.

Related policy hubs

New Jersey Medicaid policies NJ policy changes Family Medicine Internal Medicine Cardiology General Practice